Products

lals-product

US Operations - API & Intermediate

Corporate Address:

672 US 202/206 North
Building 3, Suite 205
Bridgewater, NJ 08807

Contact Info:

Phone: 1 908.450.7575
Fax: 1 908.450.1333
info@erlosen.com

Laxai’s API & Intermediate vertical is represented in US by Erlosen inc, our collaborative Marketing partner based out of New Jersey.  Erlosen comes with rich experience of marketing, sale and distribution of high quality generic drugs and speciality intermediates. It’s client base are predominantly USFDA approved manufacturing and formulation companies of North America and Asia. The therapeutic categories that we focus, but not limited to are: Anti-Infective, Cardiovascular, Metabolic disorder and Pain-management.Some of the APIs that we offer

  • Albendazole [54965-21-8]
  • Penicillamine [52-66-4]
  • Metyrosine [672-87-7]
  • TrientineHCl [112-24-3]
  • Tazarotene [118292-40-3]
  • Docosanol [661-19-8]
  • Tiopronin [1953-02-2]
  • Nitisinone [104206-65-7]
  • Carglumic Acid [1188-38-1]
  • Capecitabine [154361-50-97]
  • Bromazepam [1812-30-2]
  • Ketozalam [27223-35-4]
  • Prazosin [19216-56-9]
  • Enclomiphene Citrate [7599-79-3]
  • Glycerol Phenylbutyrate [611168-24-2]
  • Riociguat [625115-55-1]
  • Droxidopa [23651-95-8]
  • Phenoxybenzamine Hydrochloride [63-92-3]
  • Ramelteon [196597-26-9]
  • Lapatinib [231277-92-2]
  • LomitapideMesilate [202914-84-9]
  • Ivabradine [155974-00-8]
  • Deferasirox [201530-41-8]
  • Tenofovir disoproxil fumarate [202138-50-9]

For details on product offerings contact us at : info@laxaiavanti.com